Aclaris Therapeutics Inc Earnings

The next earnings date for Aclaris Therapeutics Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Aclaris Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$-0.13

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Aclaris Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/06/2025	---	$0	100.00%
06/06/2025	Before Market	$-0.12	58.62%
02/25/2025	Before Market	$-1.01	-169.33%
11/04/2024	Before Market	$-0.11	-1,000.00%
08/07/2024	Before Market	$-0.15	25.00%
05/07/2024	After Market	$-0.24	17.24%
02/27/2024	Before Market	$-0.02	94.12%
11/06/2023	Before Market	$-0.41	14.58%
08/07/2023	Before Market	$-0.42	6.67%
05/08/2023	Before Market	$-0.40	9.09%
02/23/2023	Before Market	$-0.41	8.89%
11/08/2022	Before Market	$-0.30	25.00%
08/03/2022	Before Market	$-0.31	13.89%
05/10/2022	Before Market	$-0.31	22.50%
02/24/2022	Before Market	$-0.37	-2.78%
11/02/2021	Before Market	$-0.35	-25.00%
08/05/2021	Before Market	$-0.34	-21.43%
05/07/2021	Before Market	$-0.57	-96.55%
02/25/2021	Before Market	$-0.30	-11.11%
11/04/2020	Before Market	$-0.25	16.67%
08/07/2020	Before Market	$-0.28	22.22%
05/07/2020	After Market	$-0.37	-15.63%
02/25/2020	After Market	$-0.45	-15.38%
11/07/2019	After Market	$-1.34	-135.09%
08/08/2019	After Market	$-0.76	0.00%
05/08/2019	After Market	$-0.91	-13.75%
03/18/2019	Before Market	$-0.99	0.00%
11/06/2018	After Market	$-1.06	20.30%
08/03/2018	Before Market	$-1.01	7.34%
05/08/2018	After Market	$-0.98	2.00%
03/12/2018	Before Market	$-0.74	18.68%
11/07/2017	Before Market	$-0.63	26.74%
08/08/2017	Before Market	$-0.56	21.13%
05/09/2017	After Market	$-0.48	14.29%
03/15/2017	Before Market	$-0.49	16.95%
11/03/2016	Before Market	$-0.50	24.24%
08/11/2016	Before Market	$-0.62	-1.64%
05/11/2016	Before Market	$-0.65	-35.42%
03/23/2016	After Market	$-0.28	15.15%
11/18/2015	After Market	$-5.11	-79.93%

More About Aclaris Therapeutics Inc

Website

https://www.aclaristx.com

Country

USA

Full Time Employees

Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. Its Contract Research segment provides laboratory services. The company also develops ATI-1777, a soft JAK 1/3 inhibitor in Phase 2b trial for the treatment of atopic dermatitis and other dermatologic conditions; Bosakitug (ATI-045), an anti-TSLP monoclonal antibody in Phase 2a trial to treat moderate to severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, and moderate to severe chronic obstructive pulmonary disease; ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor in Phase 2a trial for the treatment for T cell-mediated autoimmune diseases; Zunsemetinib (ATI-450), a mitogen-activated protein kinase-activated protein kinase 2 inhibitor under Phase 1b/2 trials for the treatment of metastatic breast cancer and pancreatic ductal adenocarcinoma; and ATI-052, a humanized anti-TSLP and anti-IL4R bispecific antibody in preclinical stage to treat various atopic, immunologic, and respiratory diseases, as well as an ITK selective inhibitor candidate for the treatment of autoimmune diseases. Aclaris Therapeutics, Inc. was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

“Aclaris Therapeutics Inc Earnings” Can Refer to the Aclaris Therapeutics Inc Earnings Date

Some people say “Aclaris Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Aclaris Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Aclaris Therapeutics Inc Stock on the Earnings Date

If you own Aclaris Therapeutics Inc stock (ACRS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Aclaris Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Aclaris Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Aclaris Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Aclaris Therapeutics Inc earnings or anything else related to the stock market.